ChromaDex(CDXC) - 2025 Q2 - Quarterly Results

LOS ANGELES, CA - August 6, 2025 - Niagen Bioscience, Inc. (NASDAQ:NAGE) today announced financial results for the second quarter of 2025. Second Quarter 2025 Financial Highlights Compared to Prior Year Period Recent Operational Highlights "We delivered an excellent second quarter, with $31.1 million in net sales, up 37% year-over-year, and $3.6 million in net income," said Niagen Bioscience CEO Rob Fried. "As the pioneers of this blossoming NAD+ market, we continue to invest in the future while maintaining ...